TrialJournal of the American College of Cardiology2020

Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.

Peter Izmirly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.